Peter Köhler

1.6k total citations
63 papers, 1.2k citations indexed

About

Peter Köhler is a scholar working on Oncology, Immunology and Industrial and Manufacturing Engineering. According to data from OpenAlex, Peter Köhler has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Immunology and 12 papers in Industrial and Manufacturing Engineering. Recurrent topics in Peter Köhler's work include Manufacturing Process and Optimization (11 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (9 papers). Peter Köhler is often cited by papers focused on Manufacturing Process and Optimization (11 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (9 papers). Peter Köhler collaborates with scholars based in United States, Germany and Sweden. Peter Köhler's co-authors include Paul M. Sondel, Robin Bechhofer, Barry E. Storer, Jacquelyn A. Hank, Andris Kreicbergs, J A Hank, Jeff Sosman, Kate H. Moore, Nancy S. Rosenthal and Jeffrey A. Sosman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Köhler

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Köhler United States 20 493 489 167 153 131 63 1.2k
Miguel A. Sáez Spain 17 515 1.0× 546 1.1× 184 1.1× 257 1.7× 274 2.1× 82 1.5k
István Gál Hungary 21 199 0.4× 389 0.8× 130 0.8× 349 2.3× 374 2.9× 50 1.4k
Małgorzata Wągrowska‐Danilewicz Poland 19 229 0.5× 298 0.6× 153 0.9× 225 1.5× 267 2.0× 146 1.3k
Danièle Bensoussan France 21 262 0.5× 246 0.5× 123 0.7× 348 2.3× 259 2.0× 72 1.3k
Pierre‐André Guerne Switzerland 25 223 0.5× 442 0.9× 71 0.4× 251 1.6× 407 3.1× 40 1.9k
Rashaud Senior United States 7 137 0.3× 219 0.4× 183 1.1× 169 1.1× 211 1.6× 11 1.1k
Mamoru Ito Japan 15 396 0.8× 197 0.4× 363 2.2× 215 1.4× 262 2.0× 80 1.4k
Hanh Khuu United States 22 553 1.1× 329 0.7× 98 0.6× 204 1.3× 575 4.4× 44 1.5k
W. Mohr Germany 17 189 0.4× 224 0.5× 166 1.0× 446 2.9× 274 2.1× 159 1.6k
Jacob Bejar Israel 19 201 0.4× 184 0.4× 180 1.1× 271 1.8× 278 2.1× 79 1.2k

Countries citing papers authored by Peter Köhler

Since Specialization
Citations

This map shows the geographic impact of Peter Köhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Köhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Köhler more than expected).

Fields of papers citing papers by Peter Köhler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Köhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Köhler. The network helps show where Peter Köhler may publish in the future.

Co-authorship network of co-authors of Peter Köhler

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Köhler. A scholar is included among the top collaborators of Peter Köhler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Köhler. Peter Köhler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Köhler, Peter, et al.. (2016). Cost Estimation in Engineer-to-OrderManufacturing. Open Engineering. 6(1). 9 indexed citations
3.
Dimeo, Fernando, Alexander Schmittel, Thomas Fietz, et al.. (2004). Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Annals of Oncology. 15(8). 1237–1242. 92 indexed citations
4.
Rothenberg, Mace L., Sharon P. Wilczynski, Edward V. Hannigan, et al.. (2001). Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326). Gynecologic Oncology. 82(2). 317–322. 28 indexed citations
5.
Köhler, Peter. (1993). Satire and testimony in the late rhodesian novel: John Eppel's D.G.G. Berry's "The great North road". English in Africa. 20(2). 67–88. 1 indexed citations
6.
Sosman, Jeff, Kathleen Schell, Peter Köhler, et al.. (1991). Prolonged Interleukin-2 (IL-2) Treatment Can Augment Immune Activation Without Enhancing Antitumor Activity in Renal Cell Carcinom. Cancer Investigation. 9(1). 35–48. 12 indexed citations
7.
Hamm, John, D C Tormey, Peter Köhler, et al.. (1991). Phase I study of toremifene in patients with advanced cancer.. Journal of Clinical Oncology. 9(11). 2036–2041. 26 indexed citations
8.
Köhler, Peter, et al.. (1990). Osteogenic enhancement of diaphyseal reconstruction: Comparison of bone grafts in the rabbit. Acta Orthopaedica Scandinavica. 61(1). 42–45. 9 indexed citations
9.
Köhler, Peter, John Hamm, Valerie J. Wiebe, et al.. (1990). Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer. Breast Cancer Research and Treatment. 16(S1). S–S. 21 indexed citations
10.
Albertini, Mark R., Jeffrey A. Sosman, Jacquelyn A. Hank, et al.. (1990). the influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2. Cancer. 66(12). 2457–2464. 27 indexed citations
11.
Brown, R. R., et al.. (1989). Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2.. PubMed. 49(17). 4941–4. 68 indexed citations
12.
Rozental, Jack M., H. Ian Robins, Jonathan L. Finlay, et al.. (1989). “Eight-drugs-in-one-day” chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer. 63(12). 2475–2481. 24 indexed citations
13.
Rozental, Jack M., H. Ian Robins, Jonathan L. Finlay, et al.. (1989). Eight‐drugs‐in‐one‐day chemotherapy in postirradiated adult patients with malignant gliomas. Medical and Pediatric Oncology. 17(5-6). 471–476. 16 indexed citations
14.
Köhler, Peter, Jacquelyn A. Hank, Barry E. Storer, et al.. (1989). Phase 1 Clinical Trial of Recombinant Interleukin-2: A Comparison of Bolus and Continuous Intravenous Infusion. Cancer Investigation. 7(3). 213–223. 28 indexed citations
15.
Köhler, Peter, et al.. (1989). Bacteria on stumps of amputees and the effect of antiseptics. Prosthetics and Orthotics International. 13(3). 149–151. 19 indexed citations
16.
Köhler, Peter, et al.. (1988). Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions. Cancer Immunology Immunotherapy. 26(1). 74–82. 7 indexed citations
17.
Köhler, Peter, et al.. (1988). A new in-built device for one-point stepless prosthetic alignment. Prosthetics and Orthotics International. 12(2). 103–104. 2 indexed citations
18.
Sosman, Jeffrey A., Peter Köhler, Jacquelyn A. Hank, et al.. (1988). Repetitive Weekly Cycles of Recombinant Human Interleukin-2: Responses of Renal Carcinoma With Acceptable Toxicity1. JNCI Journal of the National Cancer Institute. 80(1). 60–63. 107 indexed citations
19.
Köhler, Peter. (1986). ITALY'S RENAISSANCE SUPERLINERS..
20.
Köhler, Peter. (1986). HANDS ACROSS THE SEA: DEN NORSKE AMERIKALINJE..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel A. Sáez Breakdown of academic impact, for papers by István Gál Breakdown of academic impact, for papers by Małgorzata Wągrowska‐Danilewicz Breakdown of academic impact, for papers by Danièle Bensoussan Breakdown of academic impact, for papers by Pierre‐André Guerne Breakdown of academic impact, for papers by Rashaud Senior Breakdown of academic impact, for papers by Mamoru Ito Breakdown of academic impact, for papers by Hanh Khuu Breakdown of academic impact, for papers by W. Mohr Breakdown of academic impact, for papers by Jacob Bejar
Rankless by CCL
2026